Latest total assets for VRCA: $36M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Verrica Pharmaceuticals (VRCA) currently reports a total assets of $36M as of June 2026. That compares with $39M in the prior-year period — down 7.9% year over year. Use the charts on this page to explore Verrica Pharmaceuticals's total assets history and peer comparisons.
Verrica Pharmaceuticals's total assets decreased from $39M to $36M — a 7.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Verrica Pharmaceuticals reported $36M in total assets as of June 2026. That compares with $39M in the prior-year period — down 7.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total assets of $36M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Verrica Pharmaceuticals, and consider following VRCA for alerts when major investors trade the stock.
Verrica Pharmaceuticals is classified in the Healthcare sector. On total assets, it currently shows $36M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VRCA with unrelated industries.